TREM2 and Nasu-Hakola disease: Herein, transcriptional profiling and functional analyses of the TREM2 p.Q33X mutation reveal that it leads to dysregulation of lysosomal function, lipid metabolism and microglia activation, and these phenotypes are recapitulated in brain tissues from NHD patients.